輸入代號或公司名稱後按 Enter
4119

旭富

+0.40 (+0.69%)最後更新 2026-09-11
台灣 · 上市 · 生技醫療業
58.30342成交張數116.60本益比1.31股價淨值比1.29%殖利率2026-09-11資料日期

每股盈餘

柱為單季 EPS,線為近四季合計;近十年

季度單季 EPS年增近四季 EPS歸屬母公司淨利(億)淨利率ROE(季)ROE(近四季)
2026Q2-0.11-157.9%0.50-0.13-4.7%-0.24%1.12%
2026Q10.17-37.0%0.800.205.3%0.37%1.75%
2025Q40.33-15.4%0.900.3910.9%0.72%1.98%
2025Q30.11-96.5%0.960.145.5%0.26%2.14%
2025Q20.19-63.5%4.040.236.1%0.42%9.25%
2025Q10.27-27.0%4.370.328.8%0.58%9.77%
2024Q40.394.470.4711.7%0.86%10.11%
2024Q33.19746.8%4.003.8190.9%7.28%10.14%
2024Q20.52-71.4%1.190.6215.8%1.22%3.02%
2024Q10.37-36.7%2.490.4514.4%0.87%6.25%
2023Q4-0.08-111.1%2.70-0.04-1.2%-0.08%6.75%
2023Q30.38-15.3%3.500.3513.7%0.86%9.81%
2023Q21.8241.9%3.572.0063.7%5.12%10.24%
2023Q10.5855.8%3.030.6318.6%1.73%9.37%
2022Q40.722.830.7934.8%2.19%8.89%
2022Q30.4461.9%1.920.4916.0%1.38%6.09%
2022Q21.283421.4%1.751.4077.4%4.07%5.60%
2022Q10.37-0.8%0.500.4121.9%1.23%1.64%
2021Q4-0.180.51-0.20-14.5%-0.59%1.68%
2021Q30.27-84.1%-1.860.3013.1%0.89%-5.83%
2021Q20.04-98.4%-0.410.042.1%0.11%-1.31%
2021Q10.38-80.2%1.770.4212.9%1.25%5.53%
2020Q4-2.55-410.6%3.29-2.79-56.0%-8.02%10.60%
2020Q31.7318.4%6.661.8927.8%5.34%20.75%
2020Q22.2152.8%6.392.4233.2%6.82%21.09%
2020Q11.9027.2%5.632.0826.6%5.85%17.54%
2019Q40.82-18.7%5.220.8917.2%2.61%17.09%
2019Q31.4625.6%5.411.6025.5%4.86%18.24%
2019Q21.456.4%5.121.5826.1%4.81%18.14%
2019Q11.50167.5%5.031.6427.2%4.99%17.31%
2018Q41.0185.4%4.091.1023.7%3.49%14.57%
2018Q31.16213.7%3.631.2724.4%4.18%13.27%
2018Q21.36274.0%2.831.4928.1%5.00%10.69%
2018Q10.5618.5%1.840.6114.3%2.06%6.56%
2017Q40.5482.9%1.750.5917.8%2.04%6.37%
2017Q30.37-56.4%1.500.4111.5%1.43%5.62%
2017Q20.36-70.6%1.980.4014.0%1.33%7.63%
2017Q10.47-68.5%2.860.5115.7%1.66%10.30%
2016Q40.303.880.3413.2%1.12%
2016Q30.850.9419.8%3.16%